RAPT THERAPEUTICS INC (RAPT) Stock Income Statement
NASDAQ:RAPT - Nasdaq - US75382E1091 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 1.53M | 3.81M | 5.04M | |||
| Operating Expenses | 128.99M | 127.06M | 87.32M | 73.02M | 58.26M | |||
| Research and Development | 101.20M | 101.00M | 67.08M | 56.99M | 45.49M | |||
| Selling, General, and Administrative Expenses | 27.78M | 26.06M | 20.24M | 16.04M | 12.77M | |||
| Operating Income | -128.99M | -127.06M | -85.80M | -69.21M | -53.21M | |||
| Other Income/Expense | 8.55M | 10.26M | 1.96M | 10.00K | 1.31M | |||
| Income Before Taxes | -120.43M | -116.80M | -83.84M | -69.20M | -51.90M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 990.00K | |||
| Net Income | -120.43M | -116.80M | -83.84M | -69.20M | -52.89M | |||
| EBITDA | -127.72M | -125.85M | -84.75M | -68.21M | -52.09M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.13 | -3.05 | -2.58 | -2.53 | -2.19 | |||
| Non GAAP EPS | -3.12 | -3.04 | -2.58 | -2.53 | -2.19 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -5479.74% | -1816.27% | -1049.40% | |||
| Operating Profit Margin | N/A | N/A | -5607.84% | -1816.54% | -1055.75% | |||
All data in USD